Found 7 matching trials
Single Rising Dose Study of BI 144807 Powder in Bottle in Healthy Male Volunteers PHASE1 This first-in-man trial forms the basis for potential clinical development ...
Show More Location
1313.1.1 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
A 4 Week Study With BI 144807 in Patients >= 50 Years With Wet Age Related Macular Degeneration PHASE2 The present trial will use an open label design to investigate the effect o...
Show More Location
1313.20.43001 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Bioavailability of BI 144807 Given Alone and in Combination With Ketoconazole in Healthy Male Volunteers PHASE1 This trial investigates the influence of oral ketoconazole on the pharmacok...
Show More Location
1313.7.1 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Clinical Drug Trial in Healthy Male Subjects to Determine and Compare the Blood Concentrations of BI 144807 Following Administration as Oral Solution and Tablet Under Fasted and Fed Conditions PHASE1 The purpose of this trial is to investigate the relative bioavailability of...
Show More Location
1313.9.1 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Multiple Rising Dose Study of BI 144807 Powder in Bottle in Mild Asthmatic Patients PHASE1 In this trial the safety, tolerability, pharmacokinetics and exploratory ph...
Show More Location
1313.2.44001 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Evaluate the Effects and Safety of ALK4290 in Patients With Newly Diagnosed Wet Age-Related Macular Degeneration PHASE2 This study will evaluate the therapeutic effects and safety of 800 mg ALK42...
Show More Location
Jahn Ferenc South-Pest Hospital and Clinic
Learn More & Join Trial
Evaluate the Therapeutic Effects and Safety of ALK4290 in Patients With Refractory Wet Age-Related Macular Degeneration PHASE2 This study will evaluate the therapeutic effects and safety of 800 mg ALK42...
Show More Location
Jahn Ferenc South-Pest Hospital and Clinic
Learn More & Join Trial